Overview
DCBO market data
Price History
DCBO price chart
Valuation & Profitability
- P/E (TTM)
- 14.34 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.28 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.54 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $19.87 – $45.62 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $695.2 · P/B 8.42 · P/S 1.97.
Company news
Needham Reiterates Buy on Docebo, Maintains $31 Price TargetBenzinga · Jul 17, 2026, 4:49 PM
Docebo shares are trading higher after the company reported its preliminary unaudited Q2 2026 financial results.Benzinga · Jul 17, 2026, 2:29 PM
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On FridayBenzinga · Jul 17, 2026, 2:09 PM
Docebo Reports Preliminary Q2 Sales Of $68.3M-$68.5M, Up 12.5%-12.9% YoY; Announces $70M Stock Repurchase; Guides Q3 Sales $69.5M-$69.7M And FY2026 Sales Of $274.5M-$276.5MBenzinga · Jul 17, 2026, 10:38 AM